Literature DB >> 22964416

Notch signaling differentially regulates the cell fate of early endocrine precursor cells and their maturing descendants in the mouse pancreas and intestine.

Hui Joyce Li1, Archana Kapoor, Maryann Giel-Moloney, Guido Rindi, Andrew B Leiter.   

Abstract

Notch signaling inhibits differentiation of endocrine cells in the pancreas and intestine. In a number of cases, the observed inhibition occurred with Notch activation in multipotential cells, prior to the initiation of endocrine differentiation. It has not been established how direct activation of Notch in endocrine precursor cells affects their subsequent cell fate. Using conditional activation of Notch in cells expressing Neurogenin3 or NeuroD1, we examined the effects of Notch in both organs, on cell fate of early endocrine precursors and maturing endocrine-restricted cells, respectively. Notch did not preclude the differentiation of a limited number of endocrine cells in either organ when activated in Ngn3(+) precursor cells. In addition, in the pancreas most Ngn3(+) cells adopted a duct but not acinar cell fate; whereas in intestinal Ngn3(+) cells, Notch favored enterocyte and goblet cell fates, while selecting against endocrine and Paneth cell differentiation. A small fraction of NeuroD1(+) cells in the pancreas retain plasticity to respond to Notch, giving rise to intraislet ductules as well as cells with no detectable pancreatic lineage markers that appear to have limited ultrastructural features of both endocrine and duct cells. These results suggest that Notch directly regulates cell fate decisions in multipotential early endocrine precursor cells. Some maturing endocrine-restricted NeuroD1(+) cells in the pancreas switch to the duct lineage in response to Notch, indicating previously unappreciated plasticity at such a late stage of endocrine differentiation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964416      PMCID: PMC3475208          DOI: 10.1016/j.ydbio.2012.08.023

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  57 in total

1.  Requirement of Math1 for secretory cell lineage commitment in the mouse intestine.

Authors:  Q Yang; N A Bermingham; M J Finegold; H Y Zoghbi
Journal:  Science       Date:  2001-12-07       Impact factor: 47.728

2.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

3.  Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas.

Authors:  Sui Wang; Jingbo Yan; Daniel A Anderson; Yanwen Xu; Maneesh C Kanal; Zheng Cao; Christopher V E Wright; Guoqiang Gu
Journal:  Dev Biol       Date:  2009-12-16       Impact factor: 3.582

4.  Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells.

Authors:  B P Zambrowicz; A Imamoto; S Fiering; L A Herzenberg; W G Kerr; P Soriano
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells.

Authors:  Luca Pellegrinet; Veronica Rodilla; Zhenyi Liu; Shuang Chen; Ute Koch; Lluis Espinosa; Klaus H Kaestner; Raphael Kopan; Julian Lewis; Freddy Radtke
Journal:  Gastroenterology       Date:  2011-01-14       Impact factor: 22.682

6.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.

Authors:  G Gradwohl; A Dierich; M LeMeur; F Guillemot
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Neurogenin 3 and the enteroendocrine cell lineage in the adult mouse small intestinal epithelium.

Authors:  Matthew Bjerknes; Hazel Cheng
Journal:  Dev Biol       Date:  2006-08-07       Impact factor: 3.582

8.  Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin 3.

Authors:  H P Huang; M Liu; H M El-Hodiri; K Chu; M Jamrich; M J Tsai
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  A new method for rapidly generating gene-targeting vectors by engineering BACs through homologous recombination in bacteria.

Authors:  Vinicius Cotta-de-Almeida; Susan Schonhoff; Tomoyuki Shibata; Andrew Leiter; Scott B Snapper
Journal:  Genome Res       Date:  2003-08-12       Impact factor: 9.043

10.  Lkb1 deficiency alters goblet and paneth cell differentiation in the small intestine.

Authors:  Boris Y Shorning; Joanna Zabkiewicz; Afshan McCarthy; Helen B Pearson; Douglas J Winton; Owen J Sansom; Alan Ashworth; Alan R Clarke
Journal:  PLoS One       Date:  2009-01-23       Impact factor: 3.240

View more
  31 in total

Review 1.  Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Mark Kidd; Irvin Modlin; Kjell Öberg
Journal:  Nat Rev Clin Oncol       Date:  2016-06-07       Impact factor: 66.675

2.  Mature enteroendocrine cells contribute to basal and pathological stem cell dynamics in the small intestine.

Authors:  Yoshitatsu Sei; Jianying Feng; Leigh Samsel; Ayla White; Xilin Zhao; Sajung Yun; Deborah Citrin; J Philip McCoy; Sinju Sundaresan; Michael M Hayes; Juanita L Merchant; Andrew Leiter; Stephen A Wank
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-31       Impact factor: 4.052

3.  Distinct cellular origins for serotonin-expressing and enterochromaffin-like cells in the gastric corpus.

Authors:  Hui Joyce Li; Brian Johnston; Daniel Aiello; Daniel R Caffrey; Maryann Giel-Moloney; Guido Rindi; Andrew B Leiter
Journal:  Gastroenterology       Date:  2013-12-04       Impact factor: 22.682

4.  Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.

Authors:  Jennifer Kersigo; Lintao Gu; Linjing Xu; Ning Pan; Sarath Vijayakuma; Timothy Jones; Seiji B Shibata; Bernd Fritzsch; Marlan R Hansen
Journal:  Laryngoscope       Date:  2020-05-21       Impact factor: 3.325

5.  Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy.

Authors:  Vera J Goh; Jolene S Y Tan; Bryan C Tan; Colin Seow; Wei-Yi Ong; Yen Ching Lim; Lei Sun; Sujoy Ghosh; David L Silver
Journal:  J Biol Chem       Date:  2015-08-24       Impact factor: 5.157

6.  CtBP and associated LSD1 are required for transcriptional activation by NeuroD1 in gastrointestinal endocrine cells.

Authors:  Subir K Ray; H Joyce Li; Eric Metzger; Roland Schüle; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2014-04-14       Impact factor: 4.272

7.  High fat diet induces microbiota-dependent silencing of enteroendocrine cells.

Authors:  Lihua Ye; Olaf Mueller; Jennifer Bagwell; Michel Bagnat; Rodger A Liddle; John F Rawls
Journal:  Elife       Date:  2019-12-03       Impact factor: 8.140

8.  Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription.

Authors:  Qi Li; Yang Sun; Gopala K Jarugumilli; Shun Liu; Kyvan Dang; Jennifer L Cotton; Jordi Xiol; Pui Yee Chan; Michael DeRan; Lifang Ma; Rui Li; Lihua J Zhu; Joyce H Li; Andrew B Leiter; Y Tony Ip; Fernando D Camargo; Xuelian Luo; Randy L Johnson; Xu Wu; Junhao Mao
Journal:  Cell Stem Cell       Date:  2020-04-06       Impact factor: 24.633

9.  Peptidomics of enteroendocrine cells and characterisation of potential effects of a novel preprogastrin derived-peptide on glucose tolerance in lean mice.

Authors:  Sam G Galvin; Pierre Larraufie; Richard G Kay; Haidee Pitt; Elise Bernard; Anne K McGavigan; Helen Brant; John Hood; Laura Sheldrake; Shannon Conder; Dawn Atherton-Kemp; Van B Lu; Elisabeth A A O'Flaherty; Geoffrey P Roberts; Carina Ämmälä; Lutz Jermutus; David Baker; Fiona M Gribble; Frank Reimann
Journal:  Peptides       Date:  2021-03-17       Impact factor: 3.750

10.  Targeting development of incretin-producing cells increases insulin secretion.

Authors:  Natalia Petersen; Frank Reimann; Johan H van Es; Bernard M van den Berg; Chantal Kroone; Ramona Pais; Erik Jansen; Hans Clevers; Fiona M Gribble; Eelco J P de Koning
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.